Show simple item record

The Second Wave of COVID-19: Clinical Pharmacy Services During a Field Hospital Operation

dc.contributor.authorMazzone, Jessica
dc.contributor.authorShannon, Krysta
dc.contributor.authorRovelli, Richard
dc.contributor.authorKabbani, Racha
dc.contributor.authorAmaral, Angel
dc.contributor.authorGilchrist, Neil
dc.date2022-08-11T08:08:11.000
dc.date.accessioned2022-08-23T15:45:19Z
dc.date.available2022-08-23T15:45:19Z
dc.date.issued2021-07-26
dc.date.submitted2021-09-02
dc.identifier.citation<p>Mazzone J, Shannon K, Rovelli R, Kabbani R, Amaral A, Gilchrist N. The Second Wave of COVID-19: Clinical Pharmacy Services During a Field Hospital Operation. Hosp Pharm. 2022 Apr;57(2):205-210. doi: 10.1177/00185787211032361. Epub 2021 Jul 26. PMID: 35601713; PMCID: PMC9117775. <a href="https://doi.org/10.1177%2F00185787211032361" target="_blank" title="view article on publisher's site">View article on publisher's site</a></p>
dc.identifier.doi10.1177/00185787211032361
dc.identifier.pmid35601713
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27500
dc.description.abstractThe second wave of COVID-19 emerged in the late fall months in the state of Massachusetts and inadvertently caused a rise in the number of cases requiring hospitalization. With a field hospital previously opened in central Massachusetts during the Spring of 2020, the governor decided to reimplement the field hospital. Although operations were effectively accomplished during the first wave, the reimplementation of the field hospital came with its new set of challenges for operating a satellite pharmacy. Experiences gathered include new pharmacy operation workflows, the clinical role of pharmacy services, introduction of remdesivir treatment, and pharmacy involvement in newly diagnosed diabetes patients requiring insulin teaching. Pharmacy services were successful in adapting to the rapidly growing number in patients with a total of over 600 patients served in a course of 2 months.
dc.language.isoen_US
dc.rights© The Author(s) 2021. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectclinical services
dc.subjectdispensing
dc.subjecteducation
dc.subjectmedication safety
dc.subjectmedication process
dc.subjectHealth and Medical Administration
dc.subjectInfectious Disease
dc.subjectPharmacy and Pharmaceutical Sciences
dc.subjectVirus Diseases
dc.titleThe Second Wave of COVID-19: Clinical Pharmacy Services During a Field Hospital Operation
dc.typeJournal Article
dc.source.journaltitleHospital Pharmacy
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1305&amp;context=covid19&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/300
dc.identifier.contextkey24636338
refterms.dateFOA2022-08-23T15:45:19Z
html.description.abstract<p>The second wave of COVID-19 emerged in the late fall months in the state of Massachusetts and inadvertently caused a rise in the number of cases requiring hospitalization. With a field hospital previously opened in central Massachusetts during the Spring of 2020, the governor decided to reimplement the field hospital. Although operations were effectively accomplished during the first wave, the reimplementation of the field hospital came with its new set of challenges for operating a satellite pharmacy. Experiences gathered include new pharmacy operation workflows, the clinical role of pharmacy services, introduction of remdesivir treatment, and pharmacy involvement in newly diagnosed diabetes patients requiring insulin teaching. Pharmacy services were successful in adapting to the rapidly growing number in patients with a total of over 600 patients served in a course of 2 months.</p>
dc.identifier.submissionpathcovid19/300
dc.contributor.departmentPharmacy, UMass Memorial Medical Center
dc.source.pages00185787211032361


Files in this item

Thumbnail
Name:
00185787211032361_1_.pdf
Size:
412.0Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2021. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Except where otherwise noted, this item's license is described as © The Author(s) 2021. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).